BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 18248961)

  • 1. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease.
    Aoyagi S; Akiyama M; Shimizu H
    J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the p38 MAPK, NF-kappaB and cyclin D1 in extramammary Paget's disease.
    Lin N; Uchi H; Moroi Y; Fukiwake N; Dainichi T; Takeuchi S; Takahara M; Tu Y; Furue M; Urabe K
    J Dermatol Sci; 2007 Mar; 45(3):187-92. PubMed ID: 17207971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's disease.
    Liu H; Urabe K; Uchi H; Takeuchi S; Nakahara T; Dainichi T; Tu Y; Furue M; Moroi Y
    J Cutan Pathol; 2007 Jan; 34(1):33-8. PubMed ID: 17214852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of phosphorylated Stat3, cyclin D1 and Bcl-xL in extramammary Paget disease.
    Liu HJ; Moroi Y; Masuda T; Yasumoto S; Kokuba H; Imafuku S; Koga T; Tetsuya T; Tu YT; Aburatani H; Furue M; Urabe K
    Br J Dermatol; 2006 May; 154(5):926-32. PubMed ID: 16634897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordant over-expression of transcription factor Sp1 and vascular endothelial growth factor in extramammary Paget's disease.
    Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Uchi H; Takahara M; Uenotsuchi T; Tu YT; Urabe K; Furue M
    Int J Dermatol; 2008 Jun; 47(6):562-6. PubMed ID: 18477144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
    Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F
    Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordant overexpression of phosphorylated ATF2 and STAT3 in extramammary Paget's disease.
    Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Tomoeda H; Uenotsuchi T; Tu YT; Furue M; Urabe K
    J Cutan Pathol; 2009 Apr; 36(4):402-8. PubMed ID: 19278424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC5AC expression correlates with invasiveness and progression of extramammary Paget's disease.
    Hata H; Abe R; Hoshina D; Saito N; Homma E; Aoyagi S; Shimizu H
    J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):727-32. PubMed ID: 23581859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
    Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
    Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extramammary Paget's disease.
    Mehta NJ; Torno R; Sorra T
    South Med J; 2000 Jul; 93(7):713-5. PubMed ID: 10923963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen-positive extramammary Paget's disease--association with prostate cancer.
    Hammer A; Hager H; Steiniche T
    APMIS; 2008 Jan; 116(1):81-8. PubMed ID: 18254784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
    Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence from mucin core protein expression that some Paget's disease on areola can be of extramammary-like histogenesis and part of multisite disease.
    Ohnishi T; Shibuya S; Nemoto I; Koike S; Takizawa H; Suzuki T; Watanabe S
    Br J Dermatol; 2004 Sep; 151(3):688-92. PubMed ID: 15377360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
    Kuivanen T; Tanskanen M; Jahkola T; Impola U; Asko-Seljavaara S; Saarialho-Kere U
    J Cutan Pathol; 2004 Aug; 31(7):483-91. PubMed ID: 15239678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of insulin-like growth factor-1 receptor, p-AKT and p-ERK1/2 protein in extramammary Paget's disease.
    Liu H; Moroi Y; Yasumoto S; Kokuba H; Imafuku S; Koga T; Masuda T; Tu Y; Furue M; Urabe K
    Br J Dermatol; 2006 Sep; 155(3):586-91. PubMed ID: 16911286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of survivin and human telomerase reverse transcriptase in extramammary Paget's disease.
    Shan SJ; Zhang N; Geng SL; Zhou Z; Chen X; Nie T; Guo Z; Li C; Liu Q; Guo Y; Wei H; Chen HD
    J Cutan Pathol; 2010 Jun; 37(6):635-40. PubMed ID: 19788441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extramammary Paget's disease: a report of 2 cases and a review of the literature.
    Khoo JJ; Choon SE
    Malays J Pathol; 2003 Jun; 25(1):73-8. PubMed ID: 16196382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins.
    Pan W; Ishii H; Ebihara Y; Gobe G
    J Surg Oncol; 2003 Feb; 82(2):104-10. PubMed ID: 12561066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.